Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline.
At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...
Prosper Africa’s Tech for Trade Alliance (AT4T) is launching its latest pilot in Africa to field test a digital platform intended to bring visibility to Africa’s drug supply chains and creating a more ...